1-156868505-G-C

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM1BP4_StrongBP6

The NM_002529.4(NTRK1):​c.575G>C​(p.Gly192Ala) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000316 in 1,557,322 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/23 in silico tools predict a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G192G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00028 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00032 ( 0 hom. )

Consequence

NTRK1
NM_002529.4 missense, splice_region

Scores

4
14
Splicing: ADA: 0.8546
1
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 1.35

Publications

6 publications found
Variant links:
Genes affected
NTRK1 (HGNC:8031): (neurotrophic receptor tyrosine kinase 1) This gene encodes a member of the neurotrophic tyrosine kinase receptor (NTKR) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. The presence of this kinase leads to cell differentiation and may play a role in specifying sensory neuron subtypes. Mutations in this gene have been associated with congenital insensitivity to pain, anhidrosis, self-mutilating behavior, cognitive disability and cancer. Alternate transcriptional splice variants of this gene have been found, but only three have been characterized to date. [provided by RefSeq, Jul 2008]
NTRK1 Gene-Disease associations (from GenCC):
  • hereditary sensory and autonomic neuropathy type 4
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • familial medullary thyroid carcinoma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 3 benign, 6 uncertain in NM_002529.4
BP4
Computational evidence support a benign effect (MetaRNN=0.02289632).
BP6
Variant 1-156868505-G-C is Benign according to our data. Variant chr1-156868505-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 526742.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NTRK1NM_002529.4 linkc.575G>C p.Gly192Ala missense_variant, splice_region_variant Exon 6 of 17 ENST00000524377.7 NP_002520.2 P04629-1
NTRK1NM_001012331.2 linkc.575G>C p.Gly192Ala missense_variant, splice_region_variant Exon 6 of 16 NP_001012331.1 P04629-2X5DR71
NTRK1NM_001007792.1 linkc.485G>C p.Gly162Ala missense_variant, splice_region_variant Exon 7 of 17 NP_001007793.1 P04629-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NTRK1ENST00000524377.7 linkc.575G>C p.Gly192Ala missense_variant, splice_region_variant Exon 6 of 17 1 NM_002529.4 ENSP00000431418.1 P04629-1

Frequencies

GnomAD3 genomes
AF:
0.000276
AC:
42
AN:
152198
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.00403
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000418
AC:
69
AN:
165220
AF XY:
0.000434
show subpopulations
Gnomad AFR exome
AF:
0.000317
Gnomad AMR exome
AF:
0.000657
Gnomad ASJ exome
AF:
0.00337
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000127
Gnomad NFE exome
AF:
0.000230
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000320
AC:
450
AN:
1405124
Hom.:
0
Cov.:
33
AF XY:
0.000330
AC XY:
229
AN XY:
693646
show subpopulations
African (AFR)
AF:
0.0000626
AC:
2
AN:
31954
American (AMR)
AF:
0.000680
AC:
25
AN:
36784
Ashkenazi Jewish (ASJ)
AF:
0.00329
AC:
83
AN:
25212
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36310
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79648
European-Finnish (FIN)
AF:
0.000161
AC:
8
AN:
49698
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4842
European-Non Finnish (NFE)
AF:
0.000292
AC:
316
AN:
1082496
Other (OTH)
AF:
0.000275
AC:
16
AN:
58180
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
32
64
95
127
159
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000276
AC:
42
AN:
152198
Hom.:
0
Cov.:
33
AF XY:
0.000390
AC XY:
29
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.0000965
AC:
4
AN:
41462
American (AMR)
AF:
0.000523
AC:
8
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00403
AC:
14
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000528
Hom.:
0
Bravo
AF:
0.000348
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000117
AC:
1
ExAC
AF:
0.000165
AC:
19

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hereditary insensitivity to pain with anhidrosis Uncertain:1Benign:1
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 28, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

not provided Uncertain:1Benign:1
Mar 13, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Identified in a cohort of patients with high neuropathy, although individual clinical features or number of patients with this variant were not described (PMID: 27582484); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 27582484) -

Apr 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NTRK1: BP4 -

Inborn genetic diseases Uncertain:1
Mar 19, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.G192A variant (also known as c.575G>C) is located in coding exon 6 of the NTRK1 gene. The glycine at codon 192 is replaced by alanine, an amino acid with similar properties. This change occurs in the first base pair of coding exon 6. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Benign
0.37
.;.;T;T
Eigen
Benign
-0.015
Eigen_PC
Benign
0.041
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.87
D;D;D;D
MetaRNN
Benign
0.023
T;T;T;T
MetaSVM
Benign
-0.40
T
MutationAssessor
Benign
1.7
.;L;L;.
PhyloP100
1.4
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-1.5
N;N;N;N
REVEL
Uncertain
0.29
Sift
Benign
0.28
T;T;T;T
Sift4G
Benign
0.39
T;T;T;T
Polyphen
0.24, 1.0
.;B;D;.
Vest4
0.44
MVP
0.88
MPC
0.61
ClinPred
0.045
T
GERP RS
3.8
Varity_R
0.15
gMVP
0.61
Mutation Taster
=65/35
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.85
dbscSNV1_RF
Pathogenic
0.77
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201185829; hg19: chr1-156838297; COSMIC: COSV62327747; API